Off-market insider buying at Britannia Life Sciences (C:BLAB)

Mark Bowes-Cavanagh, a Senior Officer and 10% Holder, acquired 3,000,000 Common Shares on a direct ownership basis at a price of $0.180 through a prospectus or prospectus exempt offering on January 5th, 2022. This represents a $540,000 investment into the company's shares and an account share holdings change of 19.2%.

Britannia Life Sciences is in the Food Processing Sub Industry Group under the Consumer Non-Cyclicals Sector.

Britannia Life Sciences Inc, formerly RISE Life Science Corp, is a Canada-based vertically diversified product development company. The Company's platform provides an integrated, one-stop shop service for product development, testing, safety & compliance and consumer evaluations/trials. Its principal activities include quality ingredients, formulations, safety assessment, analytical & quality assessments, global compliance and regulation, consumer trials and evaluations for various sectors. It serves Consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.